Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mukashyaka MC"'
Autor:
Goey AKL; Sarepta Therapeutics, Inc., Cambridge, Massachusetts agoey@sarepta.com., Mukashyaka MC; Sarepta Therapeutics, Inc., Cambridge, Massachusetts., Patel Y; Sarepta Therapeutics, Inc., Cambridge, Massachusetts., Rodino-Klapac LR; Sarepta Therapeutics, Inc., Cambridge, Massachusetts., East L; Sarepta Therapeutics, Inc., Cambridge, Massachusetts.
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2024 Nov 15; Vol. 52 (12), pp. 1396-1406. Date of Electronic Publication: 2024 Nov 15.
Autor:
Mukashyaka MC; Translational Sciences Group, Sarepta Therapeutics, Inc., 215 First St., Cambridge, MA, 02142, USA. cmukashyaka@sarepta.com., Wu CL; Biology Group, Sarepta Therapeutics, Inc., Cambridge, MA, USA., Ha K; Biology Group, Sarepta Therapeutics, Inc., Cambridge, MA, USA., Zhang J; Translational Sciences Group, Sarepta Therapeutics, Inc., 215 First St., Cambridge, MA, 02142, USA., Wood J; Translational Sciences Group, Sarepta Therapeutics, Inc., 215 First St., Cambridge, MA, 02142, USA., Foley S; Biology Group, Sarepta Therapeutics, Inc., Cambridge, MA, USA., Mastis B; Biology Group, Sarepta Therapeutics, Inc., Cambridge, MA, USA., Jungels N; Biology Group, Sarepta Therapeutics, Inc., Cambridge, MA, USA., Sun H; Clinical Pharmacology Group, Sarepta Therapeutics, Inc., Cambridge, MA, USA., Shadid M; Translational Sciences Group, Sarepta Therapeutics, Inc., 215 First St., Cambridge, MA, 02142, USA., Harriman S; Translational Sciences Group, Sarepta Therapeutics, Inc., 215 First St., Cambridge, MA, 02142, USA., Hadcock JR; Translational Sciences Group, Sarepta Therapeutics, Inc., 215 First St., Cambridge, MA, 02142, USA.
Publikováno v:
Pharmaceutical research [Pharm Res] 2021 Oct; Vol. 38 (10), pp. 1731-1745. Date of Electronic Publication: 2021 Oct 20.
Autor:
Neelakantan D; Department of Pharmaceutical Sciences, College of Pharmacy, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma., Dogra S; Department of Pharmaceutical Sciences, College of Pharmacy, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma., Devapatla B; Department of Pharmaceutical Sciences, College of Pharmacy, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma., Jaiprasart P; Department of Pharmaceutical Sciences, College of Pharmacy, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma., Mukashyaka MC; Department of Pharmaceutical Sciences, College of Pharmacy, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma., Janknecht R; Department of Cell Biology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.; Peggy and Charles Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA., Dwivedi SKD; Department of Obstetrics and Gynecology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma., Bhattacharya R; Peggy and Charles Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.; Department of Obstetrics and Gynecology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma., Husain S; Department of Pathology, College of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma., Ding K; Department of Biostatistics and Epidemiology, College of Public Health, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma., Woo S; Department of Pharmaceutical Sciences, College of Pharmacy, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. sukyung-woo@ouhsc.edu.; Peggy and Charles Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Publikováno v:
Molecular cancer research : MCR [Mol Cancer Res] 2019 Jun; Vol. 17 (6), pp. 1378-1390. Date of Electronic Publication: 2019 Mar 11.